The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells

Biomaterials

Volumn 35, Issue 33, 2014, Pages 9208-9223

  Yao, Hong juan ^a   Zhang, Ying ge ^a   Sun, Lan ^a   Liu, Yan ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

CD44 receptors; Gastric cancer stem cells; Hyaluronic acid; Salinomycin; Single wall carbon nanotubes; Targeted drug delivery system

Indexed keywords

CARBON NANOTUBES; CELL CULTURE; CELL DEATH; CELL PROLIFERATION; CHEMOTHERAPY; DISEASES; DRUG DELIVERY; MOLECULAR BIOLOGY; ORGANIC ACIDS; PATHOLOGY; SINGLE-WALLED CARBON NANOTUBES (SWCN); STEM CELLS;

CD44 RECEPTORS; FUNCTIONALIZED CARBON NANOTUBES; GASTRIC CANCERS; QUANTITATIVE AND QUALITATIVE ANALYSIS; RECEPTOR-MEDIATED ENDOCYTOSIS; SALINOMYCIN; TARGETED DRUG DELIVERY SYSTEMS; TARGETING DRUG DELIVERIES;

HYALURONIC ACID;

CARBON NANOTUBE; HYALURONIC ACID; SALINOMYCIN; SINGLE WALLED NANOTUBE; PYRAN DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER STEM CELL; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CELL TRANSPORT; CULTURE MEDIUM; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; HUMAN; PRIORITY JOURNAL; STOMACH CANCER; CELL MOTION; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECTS; STOMACH TUMOR; TUMOR CELL LINE; WOUND HEALING;

APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; HUMANS; HYALURONIC ACID; MICROSCOPY, CONFOCAL; NANOTUBES, CARBON; NEOPLASTIC STEM CELLS; PYRANS; STOMACH NEOPLASMS; WOUND HEALING;

EID: 84906779006     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.07.033     Document Type: Article

References (42)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global caner statistics. CA Cancer J Clin 2011, 61:69-90.
2. Zhou B.B., Zhang H., Damelin M., Geles K.G., Grindley J.C., Dirks P.B. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 2009, 8:806-823.
3. Nakamura K., Iinuma H., Aoyagi Y., Shibuya H., Watanabe T. Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery. Oncology 2010, 78:309-315.
4. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005, 5:275-284.
5. Sun M., Zhou W., Zhang Y.Y., Wang D.L., Wu X.L. CD44+ gastric cancer cells with stemness properties are chemoradioresistant and highly invasive. Oncol Lett 2013, 5:1793-1798.
6. Takaishi S., Okumura T., Tu S., Wang S.S., Shibata W., Vigneshwaran R., et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009, 27:1006-1020.
7. Zhang C., Li C., He F., Cai Y., Yang H. Identification of CD44+CD24+ gastric cancer stem cells. JCancer Res Clin Oncol 2011, 137:1679-1686.
8. Chen T., Yang K., Yu J., Meng W., Yuan D., Bi F., et al. Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients. Cell Res 2012, 22:248-258.
9. Ghaffarzadehgan K., Jafarzadeh M., Raziee H.R., Sima H.R., Esmaili-Shandiz E., Hosseinnezhad H., et al. Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance. World J Gastroenterol 2008, 14(41):6376-6381.
10. Yoo C.H., Noh S.H., Kim H., Lee H.Y., Min J.S. Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma. JSurg Oncol 1999, 71:22-28.
11. Wang D.R., Chen G.Y., Liu X.L., Miao Y., Xia J.G., Zhu L.H., et al. CD44v6 in peripheral blood and bone marrow of patients with gastric cancer as micro-metastasis. World J Gastroenterol 2006, 12:36-42.
12. Platt V.M., Szoka F.C. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharmacol 2008, 5(4):474-486.
13. Stefano I.D., Battaglia A., Zannoni G.F., Prisco M.G., Fattorossi A., Travaglia D., et al. Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts. Cancer Chemother Pharmacol 2011, 68:107-116.
14. Wei X., Senanayake T.H., Warren G., Vinogradov S.V. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors. Bioconjug Chem 2013, 24:658-668.
15. Li S.D., Howell S.B. CD44-targeted microparticles for delivery of cisplatin to peritoneal metastases. Mol Pharm 2010, 7(1):280-290.
16. Huang J., Zhang H., Yu Y., Chen Y., Wang D., Zhang G., et al. Biodegradable self-assembled nanoparticles of poly (D,L-lactide-coglycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer. Biomaterials 2014, 35:550-566.
17. Li J.C., He Y., Sun W.J., Luo Y., Cai H.D., Pan Y.Q., et al. Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging. Biomaterials 2014, 35:3666-3677.
18. Qhattal H.S., Liu X. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes. Mol Pharm 2011, 8:1233-1246.
19. Liu Y.H., Sun J., Cao W., Yang J.H., Lian H., Li X., et al. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. Int J Pharm 2011, 421:160-169.
20. Lim E.K., Kim H.O., Jang E., Park J., Lee K., Suh J.S., et al. Hyaluronan-modified magnetic nanoclusters for detection of CD44-overexpressing breast cancer by MR imaging. Biomaterials 2011, 32:7941-7950.
21. Upadhyay K.K., Bhatt A.N., Mishra A.K., Dwarakanath B.S., Jain S., Schatz C., et al. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl L-glutamate)-b-hyaluronan polymersomes. Biomaterials 2010, 31:2882-2892.
22. Peer D., Margalit R. Loading mitomycin C inside long circulation hyaluronan targeting nano-liposomes increases its antitumor activity in three mice tumor models. Int J Cancer 2004, 108:780-789.
23. Mizrahy S., Raz S.R., Hasgaard M., Liu H., Soffer-Tsur N., Cohen K., et al. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. JControl Release 2011, 156:231-238.
24. Gupta B., Onder T.T., Jiang G., Tao K., Kuperwasser C., Weinberg R.A., et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138:645-659.
25. Fuchs D., Daniel V., Sadeghi M., Opelz G., Naujokat C. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun 2010, 394:1098-1104.
26. Kusunoki S., Kato K., Tabu K., Inagaki T., Okabe H., Kaneda H., et al. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells. Gynecol Oncol 2013, 129(3):598-605.
27. Wang Y. Effects of salinomycin on cancer stem cell in human lung adenocarcinoma. Med Chem 2011, 7:106-111.
28. Dong T.T., Zhou H.M., Wang L.L., Feng B., Lv B., Zheng M.H. Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol 2011, 18:1797-1804.
29. Liu Y., Lu W.L., Guo J., Du J., Li T., Wu J.W., et al. Apotential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes. JControl Release 2008, 129:18-25.
30. Fabbro C., Ali-Boucetta H., Da Ros T., Kostarelos K., Bianco A., Prato M. Targeting carbon nanotubes against cancer. Chem Commun 2012, 48:3911-3926.
31. Liu J., Rinzler A.G., Dai H.J., Hafner J.H., Bradley R.K., Boul P.J., et al. Fullerene pipes. Science 1998, 280:1253-1256.
32. Zhang X., Meng L., Lu Q. Cell behaviors on polysaccharide-wrapped single-wall carbon nanotubes: a quantitative study of the surface properties of biomimetic nanofibrous scaffolds. ACS Nano 2009, 3:3200-3206.
33. Wörle-Knirsch J.M., Pulskamp K., Krug H.F. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett 2006, 6:1261-1268.
34. Hirsch H.A., Iliopoulos D., Tsichlis P.N., Struhl K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 2009, 69(19):7507-7511.
35. Takehara M., Nishimura T., Mima S., Hoshino T., Mizushima T. Effect of claudin expression on paracellular permeability, migration and invasion of colonic cancer cells. Biol Pharm Bull 2009, 32:825-831.
36. Yao H.J., Ju R.J., Wang X.X., Zhang Y., Li R.J., Yu Y., et al. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery. Biomaterials 2011, 32:3285-3302.
37. Pulskamp K., Diabat S., Krug H.F. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol Lett 2007, 168:58-74.
38. Shieh Y.T., Wu H.M., Twu Y.K., Chung Y.C. An investigation on dispersion of carbon nanotubes in chitosan aqueous solutions. Colloid Polym Sci 2010, 288:377-385.
39. Piovesan S., Cox P.A., Smith J.R., Fatouros D.G., Roldo M. Novel biocompatible chitosan decorated single-walled carbon nanotubes (SWNTs) for biomedical applications: theoretical and experimental investigations. Phys Chem Chem Phys 2010, 12:15636-15643.
40. Sun H., Dai Y., Cheng G., Chang S., Li J., Zhang Y. Non-covalent modification of multi-walled carbon nanotubes with a low molecular weight chitosan and their stability in the aqueous solutions. New Chem Mater 2009, 37:78-80.
41. Patel M.P., Patel R.R., Patel J.K. Chitosan mediated targeted drug delivery system: a review. JPharm Pharm Sci 2010, 13:536-557.
42. Zhang X., Meng L., Lu Q., Fei Z., Dyson P.J. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials 2009, 30:6041-6047.